Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep819 | Reproductive and Developmental Endocrinology | ECE2020

Fetal anogenital distance is longer in polycystic ovary syndrome mothers

Perlman Sharon , Toledano Yoel , Halevy Nufar , Kivilevitch Zvi , Gilboa Yinon

Aim: Anogenital distance (AGD) is a biomarker for the prenatal hormonal environment. Scarce evidence exists regarding the effect of prenatal androgen exposure in mothers with polycystic ovary syndrome (PCOS) on the human fetal AGD. The aim of the study was to assess the prenatal sonographic measurement of AGD in fetuses of PCO mothers vs the general population.Materials and methods: AGD was measured prospectively infetuses at 26–37 weeks of gestati...

ea0037gp.20.03 | Pituitary – Hypopituitarism | ECE2015

Timing is everything? Postpartum pituitary dysfunction – variability of clinical and radiological presentation

Tirosh Amit , Iraqi Hiba Masri , Hirsch Dania , Robenshtok Eyal , Yoel Uri , Toledano Yoel , Twito Orit , Tsvetov Gloria , Shimon Ilan

Introduction: Two aetiologies are responsible for postpartum hypopituitarism; Sheehan’s syndrome which develops following traumatic labour, and lymphocytic hypophysitis. Since management of lymphocytic hypophysitis does not require surgery in most cases, pathology is usually absent, and the clinical presentation, in combination with laboratory and imaging characteristics establish the diagnosis. We aimed to describe the various patterns of presentation, including assistin...

ea0049ep819 | Pituitary - Basic | ECE2017

Non-functioning pituitary adenomas: association between clinical-pathological and molecular parameters

Barrera-Martin Ana , Vazquez-Borrego Maria-Carmen , Rebollo-Roman Angel , Garcia-Jurado Pedro-Blas , Moreno-Moreno Paloma , Alhambra-Exposito Maria-Rosa , Toledano-Delgado Alvaro , Castano Justo-P , Galvez-Moreno Maria-Angeles , Luque Raul-M

Non-functioning pituitary-adenomas (NFPAs) represent the most common pituitary tumor-type. To date, there are not clinical, biochemical, anatomo-pathological, immuno-histochemical or molecular parameters useful to predict their remission. Therefore, the aim of this study was to evaluate the potential relationship between the clinical, biochemical and pathological characteristics of patients with NFPAs, the expression profile of these tumours and the clinical outcomes during th...

ea0070yi5 | Young Investigators | ECE2020

Splicing machinery is dysregulated in craniopharyngiomas: a novel source of diagnostic, prognostic and therapeutic biomarkers

Fuentes-Fayos Antonio C , Sanchez-Medianero Teresa , Cano David A , Martínez-Ortega Antonio J , Toledano-Delgado Álvaro , Dios Elena , Venegas-Moreno Eva , Cárdenas Eugenio , Martínez-Barbera Juan P , Castaño Justo P , Soto-Moreno Alfonso , Ortega Salas Rosa M , Luque Raúl M

Craniopharyngiomas are rare benign epithelial tumors derived from remains of Rathke’s pouch. They are more prevalent in childhood, adolescence, and adults <50 years, and, commonly, are usually diagnosed after being associated with serious comorbidities when the development of the tumor is already advanced. To date, first-line therapy is usually surgery, but frequently the resection is not complete, causing high rates of recurrence. Therefore, the identification of ne...

ea0070aep529 | Endocrine-related Cancer | ECE2020

An Endocrine and metabolic interactomic approach to identify novel diagnostic/prognostic biomarkers and therapeutic targets in gliomas

Perez Gomez Jesus , Fuentes-Fayos Antonio C. , GandiÌa-GonzaÌlez Marisa L. , Cano-Rojas Alberto , Blanco-Acevedo Cristóbal , Negro-Moral Eva M. , Toledano AÌlvaro , Ramos Manuel J. , Ortega-Salas Rosa M. , CerdaÌn Sebastián , GarciÌa-MartiÌn Marisa L. , Luque Raúl M. , Solivera Juan

Gliomas are a common tumor type that affects the glial cells with common features of malignant tumors such as aggressive invasiveness, malignant transformation and vascular proliferation through the central nervous system. Currently, standard therapeutic strategies to treat malignant gliomas are not efficient having alow-rate survival (~12 months). Hence, there is a clear necessity for the identification of novel diagnostic/prognostic tools and therapeutic strategies to m...

ea0056gp200 | Pituitary Basic | ECE2018

Pharmacological characterization of somatostatin receptor subtype 3 as a potential strategy to treat non-functioning pituitary adenomas

Vazquez-Borrego Mari C , Ibanez-Costa Alejandro , Gahete Manuel D , Toledano-Delgado Alvaro , Blanco-Acevedo Cristobal , Ortega-Salas Rosa , Venegas-Moreno Eva , Vasiljevic Alexandre , Galvez-Moreno Maria A , Soto-Moreno Alfonso , Raverot Gerald , Paez-Pereda Marcelo , Culler Michael D , Castano Justo P , Luque Raul M

Non-functioning pituitary adenomas (NFPAs) represent the most common type of pituitary adenomas. NFPAs are mostly macroadenomas (>1 cm) at diagnosis and, despite their lack of functional hormone hypersecretion, are associated to severe comorbidities related to mass effect (i.e. headaches, visual defects and hypopituitarism). Transsphenoidal surgery is the mainstay of NFPAs treatment, although it is often not definitive, mainly due to the invasion of neighboring intracrania...